Restricted accessResearch articleFirst published online 1998-1
Ischemia Miocardica e Rilascio di Ormoni Vasoconstrittori Nell'ipertensione Associate ad Insufficienza Renale Cronica: Possibile Ruolo Della Malattia Coronarica Dei Piccoli Vasi
StamlerJ., WentworthD.N., NeatonJ.D.Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension1989; 13(Suppl 1): 2S–12S.
2.
CasaleP.N., DevereuxR.B., MilnerM.Value of echocardiographic left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med1986; 105: 173–8.
3.
HutingJ., KramerW., CharraB., LaurentG., WizemannV., SchutterleG.Asymmetric septal hypertrophy and left atrial dilatation in patients with end-stage renal disease long-term hemodialysis. Clin Nephrol1989; 32: 276–83.
4.
SilberbergJ.S., BarreP.E., PrichardS.S., SnidermanA.D.Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int1989; 36: 286–90.
5.
ParacuolloD., EspositoE., Di BenedettoA.Cardiac morphology evaluation in patients with chronic renal failure. In: AndreucciV.E., Dal CantonA. (Eds). New Therapeutic Strategies in Nephrology.Kluwer Academic Publishers, Norwell, MA, U.S.A., 1991: 162–8.
6.
CookeR.C., GannD.S., WheltonP.K.Hormonal responses to acute volume changes in anephric subjects. Kidney Int1983; 23: 71–8.
7.
BurgesE.D.Cardiac vagal denervation in hemodialysis patients. Nephron1982; 30: 228–30.
8.
CorderG.N., SharmaJ., McDonaldR.H.Variable levels of plasma catecholamines and dopamine beta-hydroxylase in hemodialysis patients. Nephron1980; 25: 267–72.
9.
RemmeW.J., KruyssenD.A., LookM.P., BootsmaM., de LeeuwP.W.Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans. J Am Coll Cardiol1994; 23: 82–91.
10.
BernardiD., BerniniL., CiniG., GhioneS., BonechiI.Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients. Am Heart J1985; 109: 539–45.
11.
VanhoutteP.M.Is endothelin involved in the pathogenesis of hypertension?Hypertension1993; 21: 747–51.
12.
KohnoM., YasunariK., MurakawaK.I.Plasma immunoreactive endothelin in essential hypertension. Am J Med1990; 88: 614–8.
13.
ShichiriM., HirataY., AndoK.Plasma endothelin levels in hypertension and chronic renal failure. Hypertension1990; 15: 493–6.
14.
KoyamaH., TabataT., NishizawaY., InoueT., MoriiH., YamajT.Plasma endothelin levels in patients with uremia. Lancet1989; i: 991–2.
15.
YasudaM., KonhoM., TharaA.Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J1990; 119: 801–6.
16.
WatanabeT., SuzukiN., ShimamotoN.Endothelin in myocardial infarction. Nature1990; 334: 114.
17.
YangZ., RichardV., Von SegesserL.Thresold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: A new mechanism of vasospasm?Circulation1990; 82: 188–95.
18.
Toyo-okaT., AizawaT., SuzukiN.Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation1991; 83: 476–83.
19.
ClozelJ.P., SprecherU.Influence of low perfusion pressure on effect of endothelin on coronary vasculary bed. Am J Physiol1991; 260: H893–901.
PetersenC.L., HansenA., FrandsenE.Endothelin release and enhanced regional myocardial ischemia induced by cold-air inhalation in patients with stable angina. Am Heart J1994; 128: 511–6.
22.
PepineC.J.Circadian variations in myocardial ischemia: implications for managment. JAMA1991; 265: 386–90.
23.
RoccoM.B., NabelE.G., SelwynA.P.Circadian rhythms and coronary artery disease. Am J Cardiol1987; 59: 13C–7C.
24.
AmadiA., PonikowskiP., CoatsA.J.S.Role of catecholamines and sympathetic activation as a risk factor for coronary artery disease. J Cardiovasc Risk1995; 2: 222–8.
25.
HelinP., LorenzenI., GarbarschC., MathiesenM.E.Arteriosclerosis in rabbit aorta induced by noradrenaline. Atherosclerosis1970; 12: 125–32.
26.
NapoliC., Di GregorioF., SoriceP.High prevalence of myocardial ischemia and vasoconstrictive hormonal release in hypertension during chronic renal failure. Nephron1997; 76: 434–44.
27.
SahnD.J., DeMariaA., KissloJ., WeymanA.The Committee on M-mode standardization of the American Society of Echocardiography. Recomendations regarding quantitation in M-mode echocardiography: Result of a survey of echocardiographic measurements. Circulation1978; 58: 1072–83.
28.
HenschkeC.I., RisserT.A., SandorT., HanlonW.B., NeumannA., WynneJ.Quantitative computer-assisted analysis of left ventricular wall thickening and motion by 2-dimensional echocardiography in acute myocardial infarction. Am J Cardiol1983; 52: 960–4.
29.
LeppoJ.A., DePueyE.G., JohnsonL.L.A review of cardiac imaging with Sestamibi and Teboroxime. J Nucl Med1991; 32: 2012–22.
30.
LiguoriA., Di GregorioF., NapoliC.Atrial natriuretic factor and sympathetic activation in human heart failure. Eur J Pharmacol Sci1994; 16: 61–7.
31.
CiafrèS.A., DArmientoF.P., LiguoriA.Angiotensin II evokes the release of ET-1 from human endothelial cells in vitro. Am J Clin Pathol1992; 98: 379–80.
32.
LiguoriA., Di GregorioF., NapoliC.Effects of blood loading on left ventricular function in chronic uremics with arteriovenous fistula. Chest1993; 103(Suppl. A); 192S.
33.
SmartS.C.The clinical utility of echocardiography in the assessment of myocardial viability. J Nucl Med1994; 35(Suppl): 49S–58S.
34.
FrankenP.R., De GeeterF., DendaleP., BlockP., BossuytA.Regional distribution of 1–123 (otho-io-dophenyl)-pentadecanoic acid and Tc-99m MIBI in relation to wall motion after thrombolysis for acute myocardial infarction. Nucl Med Commun1993; 14: 310–7.
35.
TamakiN., KawamotoM., YonekuraY.Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med1992; 33: 659–67.
36.
LiguoriA., NapoliC., SoriceP.Early alteration of left ventricular diastolic function in hypertensive patients on maintenance hemodialysis. Kidney Int1993; 43: 759–60.
37.
NapoliC., LiguoriA., SoriceP.Relations between vasoactive hormones and diastolic function in hypertensive uremics. J Intern Med1996; 240: 1–6.
38.
FoleyR.N., ParfreyP.S., HarnettJ.D., KentJ.M.Impact of hypertension on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Kidney Int1996; 49: 1379–83.
39.
HoughtonJ.F., FrankM.J., CarrA.A., von DohlenT.W., PisantL.L.M.Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol1990; 15: 43–51.
40.
OpherkD., MallG., ZebeH.Reduction of coronary reserve; a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation1984; 69: 1–7.
41.
JamesT.N.Morphologic characteristics and functional significance of focal fibromuscular dysplasia of small coronary arteries. Am J Cardiol1990; 65: 12G–22G.
42.
WassermanA.G., KatzR.G., VargheseP.J.Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain. N Engl J Med1984; 311: 1276–80.
43.
Guideline for clinical use of cardiac radionuclide imaging. Report of the American College of Cardio-logy/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol1995; 25: 521–47.0
AmannK., WiestG., ZimmerG., GretzN., RitzE., MallG.Reduced capillary density in the myocardium of uremic rats. Kidney Int1992; 42: 1079–85.
46.
LiguoriA., SoriceP., Di GregorioF., LecceseM., MansiL., NapoliC.Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism. Eur Heart J1997; 18(Suppl. A): 532S.
47.
WheelerD.C., SwenyP., VargheseZ.Hyperlipidemia and atherosclerosis in chronic dialysis patients. In: MaherJ.F. (Ed). Replacement of renal function by dialysis.Boston, Kluwer Academic Publishers, 1989: 798–807.
48.
FalaticoR., UnderwoodD.C., CheungW.M.Coronary vaso-constrictor and aritmogenic properties of endothelin in the dog. Pharmacolo-gist1989; 31: 150–5.
